Table 1.
Sex | n a | Age | n | BMI b | n | CEA c | n | No. Lymph Nodes | n | T-stage | n | LVI d | n | KRAS | n |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F e | 7 | 30–39 | 1 | 15–19 | 1 | 0–1 | 1 | 10–14 | 8 | 2 | 2 | Yes | 2 | Yes | 8 |
M f | 3 | 40–49 | 1 | 20–24 | 0 | 2–3 | 5 | 15–19 | 1 | 3 | 6 | No | 8 | No | 2 |
50–59 | 4 | 25–29.9 | 6 | 4–5 | 1 | 20–24 | 1 | 4 | 2 | ||||||
60–69 | 2 | ≥30 | 3 | 6–7 | 3 | ||||||||||
70–79 | 2 |
a, n = number of patients, b: BMI: body mass index = weight (kg)/height m2. c, CEA: carcinoembryonic antigen. d, LIV: lympho-vascular invasion. e, F: female. f, M: male.